EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary
Introduction
EUROCARE, which began in 1990,1, 2, 3 is the largest co-operative cancer registry-based study on the survival and care of European cancer patients. Its aims are to monitor, analyse and explain cancer survival trends and between-country differences in survival and care. Summary results of EUROCARE-4, pertaining to patients diagnosed in 1995–1999 and later, have already been published.4, 5 The aim of the present paper is to illustrate and comment on the results of survival analyses in greater detail for each cancer site included in EUROCARE-4 by country, follow-up interval, age at diagnosis and sex. In addition to these conventional survival analyses − presented in the previous EUROCARE projects − the present paper also analyses 5-year survival conditional to surviving the first year after diagnosis (5-year conditional survival). Overall survival is greatly influenced by the mortality that occurs soon after diagnosis, due in part to perioperative mortality, but also to advanced disease stage or significant comorbidity at diagnosis.
In order to provide an indication of within-country variation in survival, we also give, for selected cancers, survival for individual cancer registries (CRs) within countries, and coefficients of within-country survival variation.
Section snippets
Cancer cases
This analysis was carried out on 2,718,346 adult (aged ⩾15 years) cancer cases diagnosed in 1995–1999. A detailed description of the dataset used for the analysis is reported elsewhere in this issue.6 The data provided by the Polish cancer registry of Kielce were not included in this analysis due to partial incompleteness of follow-up for vital status. A total of 82 cancer registries from 23 European countries were therefore considered. For 13 countries (Austria, Denmark, Finland, Iceland,
Results
The main results are presented as a series of pages (938–983), one for each cancer site. The top left table on each page shows the number of men, of women and the total diagnosed with the cancer in each country, arranged in 5 European regional groupings: northern Europe (Denmark, Finland, Iceland, Norway and Sweden); the UK (England, Wales, Scotland and Northern Ireland) and Ireland; central Europe (France, Belgium, Austria, Germany, the Netherlands and Switzerland), southern Europe (Italy,
Conflict of interest statement
None declared.
EUROCARE-4 Working Group
Austria: W Oberaigner (Tyrol Cancer Registry); M Hackl (Austrian National Cancer Registry); Belgium: E Van Eycken; Martine Verstreken (Flemish Cancer Registry), Czech Republic: J Holub, L Jurickova (West Bohemia Cancer Registry); Denmark: HH Storm; G Engholm (Danish Cancer Society, Dept. Cancer Prevention & Documentation); Finland: T Hakulinen (Finnish Cancer Registry); France: A Belot (FRANCIM); G Hédelin, M Velten (Bas-Rhin Cancer Registry); I Tron, E Le Gall (Bretagne Childhood Cancer
Acknowledgements
We thank Don Ward for help with the English, and Chiara Margutti for editorial support. The EUROCARE-4 project was supported by the Compagnia di San Paolo di Torino.
References (58)
- et al.
EUROCARE Working group. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study
Lancet Oncol
(2007) - et al.
Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data
Lancet Oncol
(2007) - et al.
The EUROCARE-4 database on cancer survival in Europe: Data standardization, quality control and methods of statistical analysis
Eur J Cancer
(2009) - et al.
Standard cancer patient population for age standardising survival ratios
Eur J Cancer
(2004) - et al.
Survival trends in European cancer patients diagnosed from 1988 to 1999
Eur J Cancer
(2009) - et al.
Early diagnosis, not differential treatment, explains better survival in service screening
Eur J Cancer
(2005) - et al.
European health systems and cancer care
Ann Oncol
(2003) - et al.
Cancer survival in the elderly: effects of socio-economic factors and health care system features (ELDCARE project)
Eur J Cancer
(2006) - et al.
The cancer survival gap between elderly and middle-aged patients in Europe is widening
Eur J Cancer
(2009) - et al.
The prognostic role of gender in survival of adult cancer patients. EUROCARE Working Group
Eur J Cancer
(1998)
The advantage of women in cancer survival: An analysis of EUROCARE-4 data
Eur J Cancer
Incidental detection of population-based prostate cancer incidence rates through transurethral resection of the prostate
Urol Oncol
Prostate-cancer mortality in the USA and UK in 1975–2004: an ecological study
Lancet Oncol
Ten-year survival and risk of relapse for testicular cancer: a EUROCARE high resolution study
Eur J Cancer
Bladder cancer: improving care with better classification and risk stratification
J Urol
The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis
Ann Oncol
Gender differences in stage-adjusted bladder cancer survival
Urology
Mode of presentation of renal cell carcinoma provides prognostic information
Urol Oncol
From the bench to the bedside: emerging new treatments in multiple myeloma
Best Pract Res Clin Haematol
Survival of cancer patients in Europe: the EUROCARE Study: IARC Scientific Publications No. 132
Survival of cancer patients in Europe: the EUROCARE-2 Study: IARC Scientific Publications No. 151
Survival of cancer patients in Europe: the EUROCARE-3 Study
Ann Oncol
International classification of diseases for oncology
Cancer survival corrected for heterogeneity in patient withdrawal
Biometrics
Coding criteria of bladder cancer: effects on estimating survival
Epidemiol Prev
Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries
J Natl Cancer Inst
Cancer surveillance series: interpreting trends in prostate cancer–part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates
J Natl Cancer Inst
Advances in the treatment of haematological malignancies: optimal sequence of CML treatment
Ann Oncol
Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International breast cancer screening network (IBSN) and the European network of pilot projects for breast cancer screening
Int J Epidemiol
Cited by (744)
Epidemiology, Management, and Survival Outcomes of Germ Cell Cancer in Southern Portugal: A Population-Based Study (2008-2012)
2024, Clinical Genitourinary CancerColorectal cancer recurrence and its impact on survival after curative surgery: An analysis based on multistate models
2023, Digestive and Liver DiseaseThe Effect of Diet on Breast Cancer Recurrence: The DIANA-5 Randomized Trial
2024, Clinical Cancer Research